Stay updated with breaking news from Treefrog Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Colin Kellaher Vertex Pharmaceuticals has struck an exclusive licensing agreement with privately held TreeFrog Therapeutics in a bid to bolster production of its cell therapies for type-1...
Vertex obtains an exclusive license to TreeFrog's C-StemTM manufacturing technology in type 1 diabetes TreeFrog and Vertex to collaborate on scale-up of fully differentiated, insulin-producing...
The tissue banking market is experiencing a surge in demand due to several factors: the growing prevalence and occurrence of chronic illnesses, the expanding...
An AI-designed medicine for Inflammatory Bowel Disease enters Phase 1 clinical trials. Artificial Intelligence Biotech Company, Insilico Medicine, has reportedly entered the first phase of its clinical trials for the ISM5411.
/PRNewswire/ -- DelveInsight's Drug-Eluting Balloons Market Insights report provides the current and forecast market analysis, individual leading drug-eluting...